PE20011077A1 - Derivados de cromano que tiene afinidad por receptores de estrogenos - Google Patents
Derivados de cromano que tiene afinidad por receptores de estrogenosInfo
- Publication number
- PE20011077A1 PE20011077A1 PE2001000199A PE2001000199A PE20011077A1 PE 20011077 A1 PE20011077 A1 PE 20011077A1 PE 2001000199 A PE2001000199 A PE 2001000199A PE 2001000199 A PE2001000199 A PE 2001000199A PE 20011077 A1 PE20011077 A1 PE 20011077A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- affinity
- estrogen receptors
- chroman derivatives
- hal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A 4-BENCIL-2-FENILCROMANO DE FORMULA I DONDE R1 ES ALQUILO C1-C4, ALQUENILO C2-C4, ALQUINILO C2-C4; CON ORIENTACION CIS EN RELACION AL FENILO EN LA POSICION 2; R4 ES HAL, CF3, OH, ALQUILOXI C1-C2; R2, R3, R5 SON H, HAL, CF3, ALQUILO C1-C4, ALQUENILO C2-C4, ALQUINILO C2-C4. EL COMPUESTO I TIENE AFINIDAD POR RECEPTORES DE ESTROGENOS UTILES COMO ANTICONCEPTIVOS Y PARA EL TRATAMIENTO DE HIPERTROFIA PROSTATICA BENIGNA, TRASTORNOS CARDIOVASCULARES, MOLESTIAS MENOPAUSICAS, OSTEOPOROSIS, CONTROL DE TUMORES DEPENDIENTES DE ESTROGENOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200713 | 2000-03-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20011077A1 true PE20011077A1 (es) | 2001-12-12 |
Family
ID=8171123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000199A PE20011077A1 (es) | 2000-03-01 | 2001-02-26 | Derivados de cromano que tiene afinidad por receptores de estrogenos |
Country Status (9)
Country | Link |
---|---|
US (3) | US7214706B2 (es) |
EP (1) | EP1282615B1 (es) |
JP (1) | JP4896335B2 (es) |
AR (1) | AR027571A1 (es) |
AT (1) | ATE529419T1 (es) |
AU (1) | AU2001256164A1 (es) |
CO (1) | CO5261596A1 (es) |
PE (1) | PE20011077A1 (es) |
WO (1) | WO2001064665A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1448544T1 (sl) * | 2001-11-19 | 2007-10-31 | Lilly Co Eli | Substituirani benzopirani kot selektivni agonistiestrogenskega receptorja beta |
PL205733B1 (pl) * | 2001-11-19 | 2010-05-31 | Lilly Co Eli | Podstawiona pochodna benzopiranu, kompozycja farmaceutyczna ją zawierająca oraz jej zastosowanie |
US6630508B1 (en) | 2002-02-11 | 2003-10-07 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor β agonists |
AU2003212856A1 (en) * | 2002-03-01 | 2003-09-16 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
PT1626974E (pt) | 2003-04-21 | 2008-11-14 | Lilly Co Eli | Benzopiranos substituídos como agonistas selectivos do receptor beta de estrogénio |
US7279499B2 (en) | 2003-04-21 | 2007-10-09 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
AU2005282554A1 (en) | 2004-09-07 | 2006-03-16 | Wyeth | 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents |
WO2006044176A1 (en) | 2004-10-18 | 2006-04-27 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
WO2008091555A2 (en) | 2007-01-22 | 2008-07-31 | Gtx, Inc. | Nuclear receptor binding agents |
US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
US8063102B2 (en) | 2009-03-13 | 2011-11-22 | N.V. Organon | Tetrahydronaphthalen-2-ol derivatives |
TW201043595A (en) * | 2009-03-13 | 2010-12-16 | Organon Nv | Tetrahydronaphthalen-2-ol derivatives |
EP3490653A1 (en) | 2016-07-28 | 2019-06-05 | Cerebral Therapeutics | Implantable intraventricular sampling and infusion access device |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340276A (en) | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
DE1543749A1 (de) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
US5280040A (en) | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
CA2200423C (en) | 1996-03-26 | 2006-12-19 | Sietse Mosselman | Novel estrogen receptor |
ATE231141T1 (de) * | 1996-10-28 | 2003-02-15 | Novo Nordisk As | (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen |
US6465445B1 (en) * | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
-
2001
- 2001-02-26 JP JP2001563505A patent/JP4896335B2/ja not_active Expired - Lifetime
- 2001-02-26 WO PCT/EP2001/002144 patent/WO2001064665A1/en active Application Filing
- 2001-02-26 US US10/220,509 patent/US7214706B2/en not_active Expired - Lifetime
- 2001-02-26 AU AU2001256164A patent/AU2001256164A1/en not_active Abandoned
- 2001-02-26 AT AT01929361T patent/ATE529419T1/de not_active IP Right Cessation
- 2001-02-26 PE PE2001000199A patent/PE20011077A1/es not_active Application Discontinuation
- 2001-02-26 EP EP01929361A patent/EP1282615B1/en not_active Expired - Lifetime
- 2001-02-28 AR ARP010100917A patent/AR027571A1/es unknown
- 2001-03-01 CO CO01016343A patent/CO5261596A1/es not_active Application Discontinuation
-
2006
- 2006-01-10 US US11/328,760 patent/US7531571B2/en not_active Expired - Lifetime
-
2009
- 2009-05-08 US US12/437,883 patent/US7846966B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2001064665A1 (en) | 2001-09-07 |
US7214706B2 (en) | 2007-05-08 |
AU2001256164A1 (en) | 2001-09-12 |
AR027571A1 (es) | 2003-04-02 |
US7846966B2 (en) | 2010-12-07 |
ATE529419T1 (de) | 2011-11-15 |
EP1282615B1 (en) | 2011-10-19 |
CO5261596A1 (es) | 2003-03-31 |
US20060160889A1 (en) | 2006-07-20 |
US7531571B2 (en) | 2009-05-12 |
JP2003525285A (ja) | 2003-08-26 |
US20030069303A1 (en) | 2003-04-10 |
EP1282615A1 (en) | 2003-02-12 |
JP4896335B2 (ja) | 2012-03-14 |
US20090221695A1 (en) | 2009-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20011077A1 (es) | Derivados de cromano que tiene afinidad por receptores de estrogenos | |
ES2193874B1 (es) | Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas. | |
HK1055974A1 (en) | 9.Alpha.-chloro-6.alpha.-fuoro-17.alpha.-hydroxy-16-methyl-16-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha.by a cyclic acylgroup. | |
UA71059C2 (uk) | Спосіб одержання циталопраму | |
DE60309836D1 (de) | Kristalline zeolithische aluminosilikat-zusammensetzung: uzm-9 | |
PE20020206A1 (es) | Metodos y composiciones que comprenden nucleosidos para tratar el virus de la hepatitis c | |
GR1004074B (el) | Μεθοδος παρασκευης της σιταλοπραμης. | |
EA200300337A1 (ru) | Полиарилкарбоксамиды, применимые в качестве агентов, снижающих содержание липидов | |
ATE307182T1 (de) | Polyamine mit alkylglycidyletherendgruppen als schaumregulierungsmittel | |
DK0900234T3 (da) | 21-substituerede progesteronderivater anvendt som nye antigestagener | |
TR200101874T1 (tr) | Sitalopram hazırlanması için yöntem | |
CO5040216A1 (es) | Agonistas de adenosina a 1, proceso para su preparacion y composiciones farmaceuticas que los contienen | |
CO5190715A1 (es) | 1,2,3,4,5,6-hexahidroazepin [4,5-b] indoles que contienen arilsulfonas en la posicion 9 | |
WO2003051860A3 (en) | Substituted 2-phenyl benzofurans as estrogenic agents | |
AR036000A1 (es) | Proceso para la preparacion de derivados de indol y novedosos intermediarios | |
AR006058A1 (es) | Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido | |
BR0211899A (pt) | Processo para a preparação de um derivado de 14-hidroxinormorfinona, derivados de 14-hidroxinormorfinona e de morfinona, processo para a preparação de um composto, derivado de morfina, e, processo para a produção de noroximorfona | |
AR031941A1 (es) | Proceso para la preparacion de derivados de fenetilamina | |
PT763024E (pt) | Novos processos e intermediarios para a preparacao de derivados de piperazina | |
CO5080758A1 (es) | DERIVADOS DE 3-(2-oxo-[1,3´]BIPIRROLODINIL-3-ILIDENMETIL | |
BR0312177A (pt) | Composição condicionadora dos cabelos, método de tratamento dos cabelos e uso de uma argila hidrofobicamente modificada | |
BR0003919A (pt) | Composto desodorizador de ambiente não tóxico, livre de tensoativo aquoso monofásico e dispositivo desodorizador de ambiente | |
AR029893A1 (es) | Metodo para la preparacion de citalopram, intermediarios y composicion farmaceutica | |
TR200400293T4 (tr) | 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi. | |
DE60110975D1 (de) | Acylierungsverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |